Tens of Thousands of Commercial Truckers Leaving the Workforce Over Marijuana Testing Requirements
Washington, DC - January 27, 2023 (Investorideas.com Newswire) Over 40,000 commercially licensed truck drivers failed federally mandated drug screens for marijuana in 2022, and many did not reapply to return to work

National Cannabis Industry Association Responds to FDA Statement on Cannabidiol (CBD) Regulation
Washington, DC - January 26, 2023 (Investorideas.com Newswire) Today the Food and Drug Administration announced that it has concluded that regulations governing food and supplements would not be appropriate for Cannabidiol (CBD) products and that the agency will work with Congress to develop a new way forward.

Study: Marijuana Legalization Not Associated with Elevated Rates of Psychosis-Related Health Outcomes
Washington, DC - January 26, 2023 (Investorideas.com Newswire) State-level marijuana legalization laws are not associated with a statistically significant increase in rates of psychosis-related health outcomes

Presidential Marijuana Pardon Applications Still Unavailable Months After White House Announcement
Washington, DC - January 25, 2023 (Investorideas.com Newswire) The National Organization for the Reform of Marijuana Laws (NORML) is urging the Biden Administration to expeditiously move forward on its promise to provide pardons for low-level federal marijuana convictions.

Hemp Stock News: Global Hemp Group (CSE: GHG) Announces Execution of Exclusive Licensing Agreement for the Intellectual Property of Apollon Formularies PLC Covering the United States, Canada, and Mexico
Vancouver, British Columbia - January 23, 2023 (Newsfile Corp.) (Investorideas.com Newswire) GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is pleased to announce that further to the Company's announcement of January 11, 2023 regarding the execution of the binding LOI with Apollon Formularies Plc - (AQSE: APOL), the Parties have now executed an exclusive licensing agreement dated January 19, 2023 covering the licensing of the right to Apollon's Patent Applications and the Technology for the United States, Canada, and Mexico.

Investor Ideas Cannabis Potcasts #643: Interview with CEO of Tilt Holdings Inc. (OTC: TLLTF) (NEO: TILT)
Vancouver, Delta, Kelowna, BC - January 17, 2023 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Smoakland Adds Extra Delivery Vans Around Stadium for 49ers Playoff Game
Santa Clara, CA - January 12, 2023 (Investorideas.com Newswire) Smoakland cannabis delivery service is adding extra delivery vans around Levi's Stadium this Sunday following a meteoric 530% increase in sales during last week's playoff game against the Cardinals.

Viridian's Thursday Valuation Tracker
January 12, 2023 (Investorideas.com Newswire) This week's Viridian Value Tracker focuses on the valuation statistics of the 15 U.S Cultivation & Retail companies with over $100M market cap.

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry January 2nd, 2022 - January 6th, 2022
January 11, 2023 (Investorideas.com Newswire) Two capital raise transactions totaling $2.7M closed this week. One more transaction closed than last week, and the volume was up by $1.7M.

Hemp Stock News - Global Hemp Group (CSE: GHG) Announces Execution of Binding LOI with Apollon Formularies PLC
Vancouver, British Columbia - January 11, 2023 (Newsfile Corp.) (Investorideas.com Newswire) GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is pleased to announce that it has executed a binding Letter of Intent with Apollon Formularies Plc - (AQSE: APOL), a UK-based international pharmaceutical company developing cancer treatments from natural biologics

CENTR Brands Announces Share Payment to Hybrid Financial Ltd.
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or the "Company"). Pursuant to the previously announced Marketing Agreement dated December 2, 2021 (the "Agreement"), Hybrid Financial Ltd. ("Hybrid") was engaged to provide marketing services to CENTR. CENTR is pleased to announce it has issued shares at a price of $0.50 per share to Hybrid for its services, totaling 567,000 shares, in full satisfaction...

Halo Collective Reports Q4 Revenue Increase For its Budega(TM) Retail Stores in California
Toronto, Ontario--(Newsfile Corp. - January 27, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) ("Halo" or the "Company") a vertical integrated cannabis company, is pleased to report preliminary unaudited revenue numbers for its California operations, with retail sales increasing 16.8% for this last quarter[1]. The Company has made progress with its Budega™ VIP Program and its new location in Hollywood expected to open this year. The Company is evaluating new sales and...

Copland Road Capital Announces Closing of Oversubscribed Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2023) - Copland Road Capital Corporation (CSE: CRCC) ("Copland Road" or the "Company") is pleased to announce it has completed a non-brokered private placement financing (the "Offering") through the issuance of 2,713,500 common shares (the "Common Shares") in the capital of the Company at a price of $0.25 per Common Share for gross proceeds of $678,375. The gross proceeds raised from the Offering will be used for working...

Quinsam Declares 34th Quarterly Dividend
Toronto, Ontario--(Newsfile Corp. - January 27, 2023) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing that the Board of Directors of Quinsam has approved the Company's 34th consecutive quarterly dividend. The dividend is $0.00125 per share ($0.005 per share per year). The distribution will be paid on February 24, 2023 to shareholders of record on February 3, 2023. This dividend will be designated as an "eligible dividend" for Canadian income tax...

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
San Diego, California--(Newsfile Corp. - January 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reported that its Phase 2 clinical trial protocol has received study level approval from a central institutional review board ("IRB"). The Phase 2 study is a planned evaluation of SBI-100 Ophthalmic Emulsion ("OE") in patients with primary open angle glaucoma or ocular hypertension. SBI-100 OE...

Investor Ideas Cannabis Potcasts #643 - Interview with CEO of Tilt Holdings Inc. (OTC: TLLTF) (NEO: TILT)

Investor Ideas Potcasts #642, Cannabis News and Stocks on the Move - (TSXV: KHRN) (OTCQX: KHRNF) Village (NASDAQ: VFF)

Investor Ideas Potcasts #641, Cannabis News and Stocks on the Move - (CSE: CURA) (OTCQX: CURLF), (Nasdaq: HITI) (TSXV: HITI)

Investor Ideas Potcasts #640, Cannabis News and Stocks on the Move - Cannabis legislation in the US, cannabis retail sales in Canada and the US

Investor Ideas Potcasts #639, Cannabis News and Stocks on the Move - (CSE: IWIN), (OTCQB: XBRAF), (NASDAQ: VLNS), (CSE: RIV), (Nasdaq: HITI)